High stromal  transforming growth factor β–induced expression is a novel marker of progression and poor prognosis in gastric cancer

Journal of Surgical Oncology, EarlyView.

Source: Journal of Surgical Oncology - September 9, 2018 Category: Cancer & Oncology Authors: MasakiSuzuki MD , TakehikoYokobori MD, PhD , NavchaaGombodorj MD , MasakazuYashiro MD , AndreiTurtoi PhD , TadashiHanda MS , KyoichiOgata MD, PhD , TetsunariOyama MD, PhD , KenShirabe MD, PhD , HiroyukiKuwano MD, PhD, FACS Source Type: research